Aluminium, iron, zinc and copper Influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 6, Issue 3, 2004, Pages 291-301

  House, Emily ^a   Collingwood, Joanna ^a   Khan, Ayesha ^a   Korchazkina, Olga ^a   Berthon, Guy ^b   Exley, Christopher ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Aluminium; Alzheimer's disease; Amyloid; A 42; Chelation; Copper; Iron; Zinc

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN[1-42]; CHELATING AGENT; COPPER; DEFEROXAMINE; EDETIC ACID; IRON; ZINC;

ALZHEIMER DISEASE; ARTICLE; BETA SHEET; BRAIN PROTECTION; CHELATION THERAPY; DISSOLUTION; FIBROGENESIS; FLUORESCENCE; METAL CHELATION THERAPY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENILE PLAQUE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 3042666730     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6310     Document Type: Article

References (27)

1. C.S. Atwood, R.D. Moir and X.D. Huang et al., Dramatic aggregation of Alzheimer A beta by Cu(II) is induced by conditions representing physiological acidosis, J Biol Chem 273 (1998), 12817-12826.
2. D. Beauchemin and R. Kisilevsky, A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques, Analytical Chemistry 70 (1998), 1026-1029.
3. A.I. Bush, The metallobiology of Alzheimer's disease, Trends in Neurosciences 26 (2003), 207-214.
4. A.I. Bush, W.H. Pettingell and G. Multhaup et al., Rapid induction of Alzheimer a-beta amyloid formation by zinc, Science 265 (1994), 1464-1467.
5. R.A. Cherny, J.T. Legg and C.A. McLean et al., Aqueous dissolution of Alzheimer's disease A beta amyloid deposits by biometal depletion, J Biol Chem 274 (1999), 23223-23228.
6. J. Dong, C.S. Atwood and V.E. Anderson et al., Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence, Biochemistry 42 (2003), 2768-2773.
7. C. Exley, The precipitation of mucin by aluminium, J Inorg Biochem 70 (1998), 195-206.
8. C. Exley and O. Korchazhkina, The association of aluminium and βamyloid in Alzheimer's disease, Aluminium and Alzheimer's Disease: The Science that Describes the Link, C. Exley. Amsterdam, Elsevier, 2001, 421-434.
9. C. Exley and O.V. Korchazhkina, Promotion of formation of amyloid fibrils by aluminium adenosine triphosphate (A1ATP), J Inorg Biochem 84 (2001), 215-224.
10. A.E. Finefrock, A.I. Bush and P.M. Doraiswamy, Current status of metals as therapeutic targets in Alzheimer's disease, J Am Geriatr Soc 51 (2003), 1143-1148.
11. C.J. Frederickson and A.I. Bush, Synaptically released zinc: Physiological functions and pathological effects, Biometals 14 (2001), 353-366.
12. C. Haass, M.G. Schlossmacher and A.Y. Hung et al., Amyloid beta-peptide is produced by cultured-cells during normal metabolism, Nature 359 (1992), 322-325.
13. J. Hardy and D.J. Selkoe, Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science 297 (2002), 353-356.
14. J.A. Hardy and G.A. Higgins, Alzheimers-Disease - the Amyloid Cascade Hypothesis, Science 256 (1992), 184-185.
15. X.D. Huang, C.S. Atwood and R.D. Moir et al., Zinc-induced Alzheimer's A beta 1-40 aggregation is mediated by conformational factors, J Biol Chem 272 (1997), 26464-26470.
16. O.V. Korchazhkina, A.E. Ashcroft, T. Kiss and C. Exley, The degradation of β325-35 by the serine protease plasmin is inhibited by aluminium, Journal of Alzheimer's Disease 4 (2002), 357-367.
17. T.L. Lau, K.J. Barnham, C.C. Curtain, C.L. Masters and F. Separovic, Magnetic resonance studies of beta-amyloid peptides, Aust J Chem 56 (2003), 349-356.
18. H. Levine, Thioflavine-T interaction with synthetic Alzheimers-disease beta-amyloid peptides - detection of amyloid aggregation in solution, Protein Sci 2 (1993), 404-410.
19. P.M. May, P.W. Linder and D.R. Williams, Computer simulation of metal-ion equilibria in biofluids: Models for the low-molecular-weight complex distribution of calcium(II), magnesium(II), iron(III), zinc(II) and lead(II) ions in human bllod plasma, J Chem Soc-Dalton Trans (1977), 588-595.
20. D.R.C. McLachlan, A.J. Dalton and T.P.A. Kruck et al., Intramuscular desferrioxamine in patients with Alzheimers-disease, Lancet 337 (1991), 1304-1308.
21. K. Ono, Y. Yoshiike and A. Takashima et al., Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease, J Neurochem 87 (2003), 172-181.
22. C. Schneider and C. Exley, Silicic acid (Si(OH)4) is a significant influence upon the atomic absorption signal of aluminium measured by graphite furnace atomic absorption spectrometry (GFAAS), J Inorg Biochem 87 (2001), 45-50.
23. P. Sengupta, K. Garai and B. Sahoo et al., The amyloid beta peptide (A beta(1-40)) is thermodynamically soluble at physiological concentrations, Biochemistry 42 (2003), 10506-10513.
24. P. Seubert, C. Vigopelfrey and F. Esch et al., Isolation and quantification of soluble Alzheimers beta-peptide from biological-fluids, Nature 359 (1992), 325-327.
25. M. Shoji, T.E. Golde and J. Ghiso et al., Production of the Alzheimer amyloid-beta protein by normal proteolytic processing, Science 258 (1992), 126-129.
26. Y. Yoshiike, K. Tanemura and O. Murayama et al., New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity, J Biol Chem 276 (2001), 32293-32299.
27. 2+ inhibits the aggregation of amyloid beta-peptide(1-42) in vitro, Angew Chem-Int Edit 40 (2001), 2274-2277.